Clinical Trial

Efficacy of Preventive Ketamine on Postoperative Pain

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
* Although bariatric surgery is mainly performed laparoscopically, analgesic optimization is still essential to reduce complications and to improve the patients' comfort. In laparoscopic sleeve gastrectomy, the intraoperative peritoneal instillation of bupivacaine hydrochloride (30 ml, 0.25%) was known to be safe and effective in reducing postoperative pain, nausea, and vomiting. * Furthermore, usage of ketamine both as a pre and post-operative pain management is well established. Ketamine can be used solely or in combination with other co-adjuvant drugs, increasing their efficacy. Many therapeutic properties of ketamine have been attributed to its antagonism mechanism to N-Methyl-D-aspartate receptors.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-31 -> 2026-09-30 2026-07-08
minor Completion pushed: 2026-05-31 -> 2026-09-30 2026-07-08
Trial Details
NCT Number NCT04908579
Lead Sponsor Ain Shams University
Conditions Postoperative Pain
Enrollment 90 participants
Start Date 2021-06-15
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07